Pagerols, M
Richarte, V
Sánchez-Mora, C
Garcia-Martínez, I
Corrales, M
Corominas, M
Cormand, B
Casas, M
Ribasés, M
Ramos-Quiroga, J A
Article History
Received: 27 April 2015
Revised: 15 September 2015
Accepted: 2 November 2015
First Online: 26 January 2016
Competing interests
: Professor Casas has received travel grants and research support from Eli Lilly, Janssen-Cilag, Shire and Laboratorios Rubió. He has been on the advisory board and served as a consultant for Eli Lilly, Janssen-Cilag, Shire and Laboratorios Rubió. Dr Ramos-Quiroga has served on the speakers' bureau and acted as consultant for Eli Lilly, Janssen-Cilag, Novartis, Lundbeck, Shire, Ferrer and Laboratorios Rubió. He has received travel awards from Eli Lilly, Janssen-Cilag and Shire for participating in psychiatric meetings. The ADHD Program chaired by Dr Ramos-Quiroga has received unrestricted educational and research support from Eli Lilly, Janssen-Cilag, Shire, Rovi and Laboratorios Rubió in the past 2 years. The other authors declare no conflict of interest.